In this podcast, CCO’s expert faculty discusses approved and guideline-recommended oral HIV PrEP regimens and provides key insights on determining PrEP candidacy and important considerations for specific populations or clinical scenarios, including adolescents, pregnancy/breastfeeding, and transgender individuals.
In this podcast, CCO’s expert faculty discusses key features and available safety and efficacy data on investigational long-acting HIV pre-exposure prophylaxis strategies that are in late stages of clinical development.
In this podcast, Nicholas Chamberlain, MD, provides an overview of the different antiretroviral drug formulations and dosing strategies in various stages of clinical development for long-acting HIV PrEP—advances that collectively offer the potential for highly individualized approaches to HIV biomedical prevention.
In this podcast, I share my thoughts as a person who has chosen to take PrEP to protect myself from HIV infection. Listen in on my experience with daily oral PrEP use, how it has kept me healthy, and what opportunities future PrEP options may offer.